UniGene: Zm.103594
The AZS22-8b antibody is a rabbit polyclonal antibody specifically developed against recombinant Zea mays (maize) AZS22-8b protein . The target protein is part of the α-zein 22-kD subfamily, which belongs to the prolamin class of seed storage proteins in maize. The AZS22-8b is closely related to the larger azs22 gene family expressed during endosperm development in maize . This antibody has been developed for research use only and is not intended for diagnostic or therapeutic applications .
For optimal preservation of antibody function, the AZS22-8b antibody should be stored at either -20°C or -80°C upon receipt. It's critical to avoid repeated freeze-thaw cycles which can severely compromise antibody activity . The antibody is provided in a storage buffer containing 0.03% Proclin 300 as a preservative, along with 50% glycerol and 0.01M PBS at pH 7.4, which helps maintain stability during storage . For laboratories conducting long-term studies, aliquoting the antibody before freezing is recommended to minimize freeze-thaw cycles.
The AZS22-8b antibody has been specifically tested and validated for:
| Application | Validation Status |
|---|---|
| ELISA | Tested |
| Western Blot | Tested |
The antibody has been affinity-purified using the antigen, which ensures identification specificity when used in these applications . While these are the validated applications, researchers should conduct preliminary tests when adapting the antibody for other techniques such as immunohistochemistry or immunoprecipitation.
AZS22-8b is part of the α-zein 22-kD subfamily in maize. The Z1C subfamily, to which AZS22-8b is related, consists of 16 genes, with six being expressed during endosperm development (including azs22.4, azs22.7, azs22.8, azs22.9, azs22.19, and fl2-azs22.16) . The azs22.8 gene specifically accounts for approximately 13% of the genes belonging to the Z1C subfamily and its expression peaks approximately 18 days after pollination, concurrent with the peak expression of the fl2 gene . This suggests a coordinated role in α-zein synthesis during seed development.
When optimizing Western blot protocols for AZS22-8b detection, researchers should consider the following methodological approach:
Sample Preparation:
Extract zein proteins using the method described by Das et al., which has been validated for zein isolation
Quantify protein using Bio-Rad protein assay following manufacturer's protocol
Use approximately 5 μg of total protein for 15% SDS-PAGE analysis
Electrophoresis Conditions:
Employ 15% SDS-PAGE for optimal separation of zein proteins
Run the gel using a protein mini apparatus (Bio-Rad or equivalent)
Fix the gel using TCA and stain with EzBlue (Sigma-Aldrich) for total protein visualization
Transfer and Detection:
Use PVDF membrane rather than nitrocellulose due to the hydrophobic nature of zein proteins
Optimize primary antibody dilution (starting from 1:1000)
Use anti-rabbit HRP-conjugated secondary antibody
Include appropriate positive controls (recombinant AZS22-8b protein) and negative controls (pre-immune serum)
Researchers should note that the hydrophobic nature of zein proteins can cause aggregation during sample preparation, so inclusion of sufficient detergent is critical for accurate results.
The relationship between AZS22-8b and the Opaque2 (O2) transcription factor represents a complex regulatory network in maize endosperm development:
O2 is a basic leucine zipper (bZIP) transcription factor that primarily activates genes encoding the α-zein 22-kD subfamily .
The azs22 gene cluster, which includes genes related to AZS22-8b, contains both intact genes and pseudogenes, many of which possess a conserved O2-box located approximately 300 bp upstream of their ATG translational start codon .
This O2-box serves as the binding site for the O2 transcription factor, while a prolamine box (P-box) positioned 20 bp upstream of the O2-box is bound by the prolamine binding factor, which contains a DOF domain and can cooperate with O2 in regulating transcription .
Chromatin immunoprecipitation (ChIP) assays have demonstrated that O2 binding to the promoters of azs22 genes correlates with RNA polymerase II recruitment and gene activation during endosperm development .
The binding of O2 to azs22 gene promoters is accompanied by specific histone modifications, particularly H3K9 and H3K14 acetylation, which are markers of active transcription .
Researchers studying this regulatory network should consider that mutations in the O2-box, such as a C-to-A transversion in the ACGT core sequence, can significantly reduce O2 binding efficiency and consequently impact the expression of the corresponding gene .
To investigate developmental expression patterns using the AZS22-8b antibody, researchers should implement the following methodological approach:
Tissue Sampling Strategy:
Collect endosperm samples at specific developmental timepoints (8, 12, 15, and 23 days after pollination) to capture the full expression pattern
Include wild-type and relevant mutant samples (e.g., o2 mutants) for comparative analysis
Process samples immediately or flash-freeze in liquid nitrogen to preserve protein integrity
Experimental Techniques:
Western Blot Analysis:
Immunohistochemistry:
Section fixed endosperm tissue at 10-15 μm thickness
Use the AZS22-8b antibody (1:100-1:500 dilution range)
Include cellular markers to identify specific endosperm domains
Perform co-localization studies with other zein proteins to understand spatial organization
Chromatin Immunoprecipitation (ChIP):
This approach allows researchers to create a comprehensive developmental expression profile of AZS22-8b and understand its regulation in the context of endosperm development.
Investigating post-translational modifications (PTMs) of AZS22-8b requires a multi-faceted analytical approach:
Initial PTM Profiling:
Iso-Electric Focusing (IEF) Analysis:
Mass Spectrometry Analysis:
Immunoprecipitate AZS22-8b using the antibody
Digest with trypsin and analyze by LC-MS/MS
Search for common modifications such as phosphorylation, acetylation, and glycosylation
Use neutral loss scanning to detect phosphorylation events
Functional Validation of PTMs:
Generate phospho-specific or acetyl-specific antibodies for identified modification sites
Compare PTM patterns between different developmental stages and in response to stress conditions
Use phosphatase or deacetylase treatments to confirm the nature of modifications
PTM and Protein Localization:
Investigate whether PTMs affect protein localization within the endosperm cells
Compare distribution patterns of modified and unmodified forms using fractionation techniques
This systematic approach allows for comprehensive characterization of the PTM landscape of AZS22-8b and provides insights into how these modifications might regulate protein function during endosperm development.
When evaluating the specificity of AZS22-8b antibody compared to other zein-targeting antibodies, researchers should consider several critical factors:
Comparative Specificity Analysis:
Validation Methods for Specificity:
Western Blot Analysis with Recombinant Proteins:
Express individual recombinant zein proteins
Test reactivity of AZS22-8b antibody against each protein
Determine cross-reactivity profile quantitatively
Immunodepleton Experiments:
Pre-incubate antibody with purified AZS22-8b protein
Use depleted antibody in Western blots or immunostaining
Absence of signal confirms specificity
Genetic Validation:
Use null mutants or RNAi lines for AZS22-8b
Confirm absence of antibody binding in these genetic backgrounds
This methodical approach to specificity validation ensures reliable experimental results when using the AZS22-8b antibody for research applications.
For researchers employing AZS22-8b antibody in chromatin immunoprecipitation (ChIP) studies to investigate gene regulation, the following best practices should be implemented:
Sample Preparation Protocol:
Chromatin Extraction:
Immunoprecipitation Optimization:
Analysis of ChIP Results:
PCR Amplification:
Data Interpretation Framework:
Integration with Epigenetic Data: